PeptideBioregulator
Cartalax
Bioregulator (Khavinson tripeptide)
Typical dose
100–200 mcg
once daily · SubQ or IM · 10–20 day courses
Half-life
short
What is Cartalax?
Cartilage/musculoskeletal bioregulator (Khavinson peptide).
How Cartalax works
Khavinson bioregulator targeting cartilage/connective tissue; reported to support musculoskeletal function.
Benefits & uses
- Cartilage/joint & bone support (reported)
- Anti-inflammatory
- Organ-specific bioregulation
Common uses: Joint/cartilage support, recovery, anti-aging.
Cartalax dosage
- Typical dose
- Typical: 100–200 mcg/day SubQ or IM, in 10–20 day courses (repeated 2–3×/year). Cartilage/musculoskeletal bioregulator.
Cartalax half-life
short
Cartalax side effects
- Generally well tolerated in reported use
- Injection-site reactions possible
- Limited human safety data
Warnings & monitoring
- Research peptide — one of the more speculative bioregulators; limited human data
- Avoid in pregnancy/breastfeeding
- Peptide hypersensitivity is a contraindication
Preparation & storage
- Preparation
- Mix a 20 mg vial with 4 mL bac water → 5 mg/mL. A 200 mcg dose = 0.04 mL = 4 units.
- Reconstitution
- Reconstitute a 20 mg vial with 4 mL BAC water → 5 mg/mL. A 200 mcg dose = 0.04 mL = 4 units on a U-100 syringe (tiny dose — a more dilute recon can help accuracy).
More Bioregulator
- BronchogenBronchial/respiratory bioregulator (Khavinson peptide).
- CardiogenCardiovascular bioregulator (Khavinson peptide).
- ChonlutenBronchial/retinal bioregulator (Khavinson peptide).
- CortagenNeuro/cartilage bioregulator (Khavinson peptide).
- CrystagenImmune bioregulator (Khavinson peptide).
- LivagenLiver bioregulator (Khavinson peptide).
